Detection of stool DNA mutations before and after treatment of colorectal neoplasia

Cancer

Volumn 106, Issue 2, 2006, Pages 277-283

  Syngal, Sapna ^a,b   Stoffel, Elena ^b   Chung, Daniel ^c   Willett, Christopher ^c   Schoetz, David ^d   Schroy, Paul ^e   Jagadeesh, Deepa ^a   Morel, Kathleen ^f   Ross, Michael ^f  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^e BOSTON MEDICAL CENTER   (United States)

^f Exact Sciences Corporation   (United States)

Author keywords

Colorectal adenoma; Colorectal carcinoma; Fecal DNA; Polymerase chain reaction (PCR)

Indexed keywords

APC PROTEIN; K RAS PROTEIN; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; COHORT ANALYSIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA DETERMINATION; FECES ANALYSIS; FOLLOW UP; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FECES; FEMALE; GENES, NEOPLASM; HUMANS; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 30744447234     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21558     Document Type: Article

References (15)

1. American Cancer Society.:Cancer reference information. Atlanta: American Cancer Society, Year. Available at URL: http://www.cancer.org/docroot/CRI [accessed January 2005.]
2. Chung DC. The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology. 2000;119:854-865.
3. Forrester K, Almoguera C, Han K, et al. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature. 1987;327:298-303.
4. Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature. 1987;327:293-297.
5. Coombs NJ, Darley M, Bunyan DJ, et al. BAT-26 microsatellite instability is a sensitive indicator of mismatch repair mutation in hereditary non-polyposis colorectal cancer. Br J Surg. 2000;87:654.
6. Ahlquist DA, Skoletsky JE, Boynton KA, et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology. 2000;119:1219-1227.
7. Dong SM, Traverse G, Johnson C, et al. Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst. 2001;93:858-865.
8. Traverso G, Shuber A, Levin B, et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med. 2002;346:311-320.
9. Puig P, Urgell E, Capella G, et al. A highly sensitive method for K-ras mutation detection is useful in diagnosis of gastrointestinal cancer. Int J Cancer. 2000;85:73-77.
10. Tagore KS, Lawson MJ, Yucaitis JA, et al. Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia. Clin Colorectal Cancer. 2003;3:47-53.
11. Calistri D, Rengucci C, Bocchini R, et al. Fecal multiple molecular tests to detect colorectal cancer in stool. Clin Gastroenterol Hepatol. 2003;1:377-383.
12. Imperiale TF, Ransohoff DF, Itzkowitz, et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med. 2004;351:2704-2714.
13. Fenlon HM, Nunes DP, Schroy PC 3rd, et al. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps. N Engl J Med. 1999;341:1496-1503.
14. Pickhardt PJ, Choi JR, Hwang I, et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med. 2003;349:2191-2200.
15. Grady WM, Rajput A, Lutterbaugh JD, et al. Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer. Cancer Res. 2001;61:900-902.